Cargando…
Conflicts of Interest among Authors of Clinical Practice Guidelines for Glycemic Control in Type 2 Diabetes Mellitus
BACKGROUND: Conflict of interest (COI) is an important potential source of bias in the development of clinical practice guidelines (CPGs). OBJECTIVES: To examine rates of disclosure of COI, including financial interests in companies that manufacture drugs that are recommended in CPGs on glycemic con...
Autores principales: | Norris, Susan L., Holmer, Haley K., Ogden, Lauren A., Burda, Brittany U., Fu, Rongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796568/ https://www.ncbi.nlm.nih.gov/pubmed/24155870 http://dx.doi.org/10.1371/journal.pone.0075284 |
Ejemplares similares
-
Conflict of Interest Policies for Organizations Producing a Large Number of Clinical Practice Guidelines
por: Norris, Susan L., et al.
Publicado: (2012) -
Conflict of Interest in Clinical Practice Guideline Development: A Systematic Review
por: Norris, Susan L., et al.
Publicado: (2011) -
Conflict of Interest Disclosures for Clinical Practice Guidelines in the National Guideline Clearinghouse
por: Norris, Susan L., et al.
Publicado: (2012) -
Quality of Clinical Practice Guidelines for Glycemic Control in Type 2 Diabetes Mellitus
por: Holmer, Haley K., et al.
Publicado: (2013) -
Correction: Conflict of Interest Disclosures for Clinical Practice Guidelines in the National Guideline Clearinghouse
por: Norris, Susan L., et al.
Publicado: (2013)